C4X DISCOVERY
C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular structures with high accuracy, C4X Discovery is focused on optimising the design and development of medicines and partnering with the pharmaceutical sector to generate better, safer products. C4X Discovery is able to determine the bioactive 3D structures of a variety of biologically important molecules, including drugs, naturally occurring ligands and enzyme co-factors, and d... oes this independently of traditional methods such as computational modelling and X-ray crystallography. C4X Discovery is applying its unique technology to improve the efficiency of the drug discovery process, both in partnership with the pharmaceutical industry and across its own pipeline of high-value therapeutic targets.
C4X DISCOVERY
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2007-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.c4xdiscovery.com
Total Employee:
11+
Status:
Active
Contact:
+4401612355085
Email Addresses:
[email protected]
Total Funding:
6.71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-27 | Adorial | Adorial acquired by C4X Discovery | N/A |
Investors List
Calculus Capital
Calculus Capital investment in Post-IPO Equity - C4X Discovery
Aquarius Equity Partners
Aquarius Equity Partners investment in Venture Round - C4X Discovery
Official Site Inspections
http://www.c4xdiscovery.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.74 K
- Host name: 226.94.214.35.bc.googleusercontent.com
- IP address: 35.214.94.226
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "C4X Discovery"
Who we are โ C4XD - c4xdiscovery.com
Experts in the discovery and development of small molecule medicines for immuno-inflammatory diseases C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining โฆSee details»
C4X Discovery - Crunchbase Company Profile & Funding
C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular.See details»
C4X Discovery Ltd - LinkedIn
C4X Discovery Ltd | 4,997 followers on LinkedIn. Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines | C4XD is a pioneering Drug ...See details»
C4x Discovery Holdings 2025 Company Profile: โฆ
Mar 1, 2016 Information on valuation, funding, cap tables, investors, and executives for C4x Discovery Holdings. Use the PitchBook Platform to explore โฆSee details»
Investors โ C4XD - c4xdiscovery.com
Keep up-to-date with C4XD news Subscribe to the C4XD news stream belowSee details»
C4X Discovery - Craft
Apr 25, 2024 C4X Discovery has 5 employees across 2 locations and £1.71 m in annual revenue in FY 2023. See insights on C4X Discovery including office locations, competitors, โฆSee details»
C4X Discovery - VentureRadar
"C4X Discovery is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world-leading medicines, which โฆSee details»
C4X Discovery - Scientist.com
C4X Discovery was formed as a spin-out from the University of Manchester in 2008 and is focused on the optimisation of drug discovery and design. It uses its NMR-based technology to โฆSee details»
C4X Discovery Ltd Company Overview, Contact Details
Learn more about C4X Discovery Ltd's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
C4X Discovery Holdings Limited announces progress on
Jul 22, 2024 C4X Discovery Holdings Limited C4XD announces progress on immuno-inflammation programmes and appointment of new Board members 22 July 2024 - C4X Discovery Limited (โC4XDโ), a pioneering drug ...See details»
C4X Discovery
This presentation has been produced by C4X Discovery Holdings plc (the โCompanyโ or โC4XDโ) and has not been, and will not be, reviewed or approved by the Financial Conduct Authority of โฆSee details»
C4X Discovery - Company info. interviews, news - BiopharmaTrend
Jun 19, 2020 C4X Discovery has a state-of-the-art suite of proprietary technologies across the drug discovery process. The company's innovative DNA-based target identification platform โฆSee details»
C4X Discovery CEO and Key Executive Team - Craft.co
C4X Discovery's Non-Executive Chairman is Eva-Lotta Allan. Other executives include Clive Dix, Chief Executive Officer, Board Member; Brad Hoy, Chief Financial Officer, Board Member and โฆSee details»
C4X Discovery Company Information - Funding, Investors, and More
C4X Discovery is a company that is developing a virtual reality tool, 4Sight, to help chemists discover new drugs by visualizing the structure of complex molecules.See details»
C4X Discovery Holdings Plc (C4X Discovery Holdings Plc) - ่ฏ็ฉ็ฎก โฆ
The backbone 1 H, 13 C and 15 N resonance assignment of Ubiquitin Specific Protease 7 catalytic domain (residues 208-554) was performed in its complex with a small molecule ligand โฆSee details»
C4X Discovery Holdings plc: C4XD signs exclusive global licence โฆ
Nov 28, 2022 C4XD is eligible to receive upfront and pre-clinical payments of $16 million, plus development and commercial milestones, and tiered mid-single digit royalties Agreement โฆSee details»
Board Change โ David Lawrence appointed as Interim Chairman; โฆ
2 January 2025 โ C4X Discovery Holdings Limited (โC4XDโ), the immuno-inflammation therapeutics company, today announces that Executive Chairman, Clive Dix, has decided to โฆSee details»
C4X Discovery Holdings Limited announces progress on immuno ...
Jul 22, 2024 C4X Discovery Holdings Limited C4XD announces progress on immuno-inflammation programmes and appointment of new Board members 22 July 2024 - C4X โฆSee details»
Stolen cars are ending up at dealerships. New CBSA data ... - CBC.ca
8 hours ago The organization's executive director says sharing the data with CARFAX is a good start, though he says more can be done to make the information available to others.See details»
C4X Discovery Holdings plc Annual report and accounts 2020
43 Cash flow statements 44 Notes to the financial statements IBC Corporate information Stay up to date with the latest investor news and information at c4xdiscovery.com HighlightsSee details»